AlphaYouRC
Schedule 13D filing
RA CAPITAL MANAGEMENT, L.P. disclosed a 19.9% stake in Tyra Biosciences, Inc. (TYRA)
RA CAPITAL MANAGEMENT, L.P. reported owning 19.9% of Tyra Biosciences, Inc. (TYRA) (14,130,492 shares) in a Schedule 13D filed Sep 17, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Sep 17, 2026
- Source
- Schedule 13D
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.